MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0053643
Neocell Science Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.61 Cr
▲ 19% YoY
Net profit · FY 2024
₹4.83 Lakh
Net margin 1.3%
EBITDA · FY 2024
₹14.42 Lakh
EBITDA margin 4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Neocell Science Pharmaceuticals Private Limited
Data last updated:
Neocell Science Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC135631. Its GSTIN is 36AAGCN6935L1ZX (Telangana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Jagiyassi Nirmala and Nagaraju Nallagatla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.16 – 2 – 668/3 Malakpet, Hyderabad, Telangana, India – 500036.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.61 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹4.83 Lakh (net margin 1.3%) and EBITDA of ₹14.42 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years.
Neocell Science Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0053643). For more details, the company can be reached via its website neocellscience.com.
Company details
CIN U51909TG2019PTC135631
Registration Number 135631
Incorporation Date 23 September 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0053643
Recognitions & Rankings of Neocell Science Pharmaceuticals
Contact details
Neocell Science Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No.16 – 2 – 668/3 Malakpet, Hyderabad, Telangana, India – 500036
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neocell Science Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Neocell Science Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neocell Science Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neocell Science Pharmaceuticals Private Limited, buy the company report.
Financials of Neocell Science Pharmaceuticals Private Limited
FY 2024 filings availableNeocell Science Pharmaceuticals Private Limited reported revenue of ₹3.61 Cr (up 19% YoY) for FY 2024.
Revenue · FY 2024
₹3.61 Cr ▲ 19%
Net profit · FY 2024
₹4.83 Lakh margin 1.3%
EBITDA · FY 2024
₹14.42 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 36% over three years, including 19% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neocell Science Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neocell Science Pharmaceuticals Private Limited
Neocell Science Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagiyassi Nirmala | Director | 23 Sep 2019 | 7 Years 1 Months | Current |
| Nagaraju Nallagatla | Director | 23 Sep 2019 | 7 Years 1 Months | Current |
| Jagiyassi Harish Kumar | Director | 23 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Neocell Science Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mericana Pharmaceuticals Private Limited | ₹3.65 Cr (FY 2025) | -43.0% | Indore, Madhya Pradesh, India | |||
| Success Pharmaceuticals Private Limited | ₹3.63 Cr (FY 2025) | -3.0% | Prayagraj, Uttar Pradesh, India | |||
| Munus Pharmaceuticals Private Limited | ₹3.61 Cr (FY 2025) | -6.0% | Thrissur, Kerala, India | |||
| Neocell Science Pharmaceuticals Private Limitedthis company | ₹3.61 Cr (FY 2024) | ₹4.83 Lakh | 1.3% | 19.0% | Hyderabad, Telangana, India | |
| Bishop Trading & Pharmaceuticals Private Limited | ₹3.58 Cr (FY 2025) | -12.0% | Assam, India | |||
| Shirr Pharmaceuticals Private Limited | ₹3.57 Cr (FY 2025) | 2.0% | Thiruvananthapuram, Kerala, India | |||
| Luvis Pharmaceuticals Private Limited | ₹3.55 Cr (FY 2024) | 3.0% | Raipur, Chhattisgarh, India |
To see the full peer comparison of Neocell Science Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neocell Science Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neocell Science Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neocell Science Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCN6935L1ZX | Telangana | Active | 25 Sep 2019 |
To see the full GST registrations and return filing status of Neocell Science Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neocell Science Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jagiyassi Harish Kumar was appointed as Director on 23 Sep 2019.
AGM
Neocell Science Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Neocell Science Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Jagiyassi Harish Kumar was appointed as Director.
Appointed
Jagiyassi Nirmala was appointed as Director.
Appointed
Nagaraju Nallagatla was appointed as Director.
Incorporation
23 Sep 2019
Neocell Science Pharmaceuticals Private Limited was registered on 23 Sep 2019 with Roc Hyderabad & aged 7 years 1 month as per MCA records.
Frequently asked questions
Neocell Science Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 September 2019 (7+ years old) and is registered under CIN U51909TG2019PTC135631.
Neocell Science Pharmaceuticals has 3 current directors:
- Jagiyassi Nirmala - Director
- Nagaraju Nallagatla - Director
- Jagiyassi Harish Kumar - Director
The latest financial statements of Neocell Science Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Neocell Science Pharmaceuticals is 36AAGCN6935L1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Neocell Science Pharmaceuticals is U51909TG2019PTC135631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neocell Science Pharmaceuticals was incorporated on 23 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Neocell Science Pharmaceuticals by revenue are Mericana Pharmaceuticals Private Limited, Success Pharmaceuticals Private Limited, Munus Pharmaceuticals Private Limited, Bishop Trading & Pharmaceuticals Private Limited, Shirr Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jagiyassi Harish Kumar was appointed as Director on 23 Sep 2019. Jagiyassi Nirmala was appointed as Director on 23 Sep 2019. Nagaraju Nallagatla was appointed as Director on 23 Sep 2019.
Yes, Neocell Science Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0053643).
Neocell Science Pharmaceuticals can be reached through the website neocellscience.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Neocell Science Pharmaceuticals is at H.No.16 – 2 – 6683 Malakpet, Hyderabad, Telangana, India – 500036.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages